Fig. 1.
Fig. 1. The effect of HNE on the cofactor activity of Factor V and Va. Purified human F.V (A), and F.Va (B), (600 nmol/L) were incubated at 37°C with purified HNE (2 nmol/L in A; 60 nmol/L in B) in HBS, pH 7.4, 5 mmol/L CaCl2 and 3.0 μmol/L DAPA (•) or with 50 μmol/L PCPS (▪). Control incubation mixtures for both F.V (A) and F.Va (B) in the absence of HNE with (□) or without (○) the addition of PCPS vesicles are shown. At the times indicated, aliquots were withdrawn and HNE activity was quenched with 10.0 μmol/L AAPV-CMK in HBS, pH 7.4 containing 0.1% BSA and 500 μmol/L PCPS. F.Va cofactor activity was then determined using 1.4 μmol/L prothrombin and 5.0 nmol/L F.Xa in the prothrombinase assay (see Materials and Methods). The results shown are expressed as initial rates of mol thrombin (hIIa) generated per second per mole hF.Va.

The effect of HNE on the cofactor activity of Factor V and Va. Purified human F.V (A), and F.Va (B), (600 nmol/L) were incubated at 37°C with purified HNE (2 nmol/L in A; 60 nmol/L in B) in HBS, pH 7.4, 5 mmol/L CaCl2 and 3.0 μmol/L DAPA (•) or with 50 μmol/L PCPS (▪). Control incubation mixtures for both F.V (A) and F.Va (B) in the absence of HNE with (□) or without (○) the addition of PCPS vesicles are shown. At the times indicated, aliquots were withdrawn and HNE activity was quenched with 10.0 μmol/L AAPV-CMK in HBS, pH 7.4 containing 0.1% BSA and 500 μmol/L PCPS. F.Va cofactor activity was then determined using 1.4 μmol/L prothrombin and 5.0 nmol/L F.Xa in the prothrombinase assay (see Materials and Methods). The results shown are expressed as initial rates of mol thrombin (hIIa) generated per second per mole hF.Va.

Close Modal

or Create an Account

Close Modal
Close Modal